CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

ACUTA CAPITAL PARTNERS, LLC's Holding History (CIK: 0001582844)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024

Shares 122,900 Value ($000) $6,284 Avg Close $55.95 Range $49.48 - $62.53

Q3 2024

Shares 131,700 Value ($000) $6,730 Avg Close $51.57 Range $43.71 - $55.78

Q2 2024

Shares 135,141 Value ($000) $6,053 Avg Close $46.18 Range $41.01 - $53.70

Q1 2024

Shares 78,403 Value ($000) $3,670 Avg Close $39.13 Range $33.67 - $47.58

Q4 2023

Shares 87,500 Value ($000) $3,113 Avg Close $30.67 Range $25.35 - $37.88

Q3 2023

Shares 94,000 Value ($000) $2,796 Avg Close $20.61 Range $15.76 - $31.00

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2024	122,900	$6,284	$55.95	$49.48 - $62.53
Q3 2024	131,700	$6,730	$51.57	$43.71 - $55.78
Q2 2024	135,141	$6,053	$46.18	$41.01 - $53.70
Q1 2024	78,403	$3,670	$39.13	$33.67 - $47.58
Q4 2023	87,500	$3,113	$30.67	$25.35 - $37.88
Q3 2023	94,000	$2,796	$20.61	$15.76 - $31.00